Recombinant MAPT (Bepranemab Biosimilar) antibody

Catalog No. ABIN7597550

The Humanized Chimeric anti-MAPT (Bepranemab Biosimilar) antibody (ABIN7597550) specifically detects MAPT (Bepranemab Biosimilar). The antibody is reactive with Human samples.

Quick Overview for Recombinant MAPT (Bepranemab Biosimilar) antibody (ABIN7597550)

Target: MAPT (Bepranemab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This MAPT (Bepranemab Biosimilar) antibody is un-conjugated

Grade: Research Grade

Product Details anti-MAPT (Bepranemab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Bepranemab Biosimilar Antibody

Specificity: MAPTL, Paired helical filament-tau, MTBT1, Microtubule-associated protein tau, TAU, Neurofibrillary tangle protein, MAPT, PHF-tau

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG4 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for MAPT (Bepranemab Biosimilar)

Target: MAPT (Bepranemab Biosimilar)

Alternative Name: Bepranemab Biosimilar

Target Type: Biosimilar

Background: MAPTL, Paired helical filament-tau, MTBT1, Microtubule-associated protein tau, TAU, Neurofibrillary tangle protein, MAPT, PHF-tau

UniProt: P10636

CAS-No: 2244960-75-4